US2019249159A1PendingUtilityA1

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Assignee: NOVOZYMES ASPriority: Jun 29, 2012Filed: Apr 4, 2018Published: Aug 15, 2019
Est. expiryJun 29, 2032(~5.9 yrs left)· nominal 20-yr term from priority
C12P 2203/00C12P 19/14C12Y 302/01C12P 19/02C12N 2310/141C12N 15/1137C12N 9/2437C12N 2310/14
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to isolated polypeptides having cellulolytic enhancing activity and polynucleotides encoding the polypeptides, catalytic domains, carbohydrate binding modules and polynucleotides encoding the polypeptides, catalytic domains or carbohydrate binding modules. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or carbohydrate binding modules.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . A nucleic acid construct comprising a polynucleotide encoding a GH61 polypeptide having cellulolytic enhancing activity, wherein the polynucleotide is operably linked to one or more heterologous control sequences that direct the production of the GH61 polypeptide in a recombinant host cell, and wherein the GH61 polypeptide having cellulolytic enhancing is selected from the group consisting of:
 (a) a GH61 polypeptide having at least 95% sequence identity to the mature polypeptide of h SEQ ID NO: 4;   (b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under very high stringency conditions with the full-length complement of the mature polypeptide coding sequence of SEQ ID NO: 3 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 3; and   (c) a GH61 polypeptide encoded by a polynucleotide having at least 98% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 3.   
     
     
         22 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide has at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         23 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide has at least 96% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         24 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         25 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide has at least 98% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         26 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide has at least 99% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         27 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide comprises SEQ ID NO: 4 or the mature polypeptide of SEQ ID NO: 4. 
     
     
         28 . The nucleic acid construct of  claim 21 , wherein the GH61 polypeptide is a fragment of the mature polypeptide of SEQ ID NO: 4, and wherein the fragment has cellulolytic enhancing activity. 
     
     
         29 . A recombinant host cell transformed with the nucleic acid construct of  claim 21 . 
     
     
         30 . A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising: cultivating the recombinant host cell of  claim 29  under conditions conducive for production of the GH61 polypeptide. 
     
     
         31 . A transgenic plant, plant part or plant cell transformed with the nucleic acid construct of  claim 21 . 
     
     
         32 . A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising: cultivating the transgenic plant or plant cell of  claim 31  under conditions conducive for production of the GH61 polypeptide, and recovering the GH61 polypeptide. 
     
     
         33 . A recombinant host cell transformed with a nucleic acid construct comprising a polynucleotide encoding a GH61 polypeptide having cellulolytic enhancing activity, wherein the polynucleotide is operably linked to one or more control sequences that direct the production of the GH61 polypeptide in the recombinant host cell, wherein the GH61 polypeptide is heterologous to the recombinant host cell, and wherein the GH61 polypeptide having cellulolytic enhancing is selected from the group consisting of:
 (a) a GH61 polypeptide having at least 95% sequence identity to the mature polypeptide of h SEQ ID NO: 4;   (b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under very high stringency conditions with the full-length complement of the mature polypeptide coding sequence of SEQ ID NO: 3 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 3; and   (c) a GH61 polypeptide encoded by a polynucleotide having at least 98% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 3.   
     
     
         34 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide has at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         35 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide has at least 96% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         36 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         37 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide has at least 98% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         38 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide has at least 99% sequence identity to the mature polypeptide of SEQ ID NO: 4. 
     
     
         39 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide comprises SEQ ID NO: 4 or the mature polypeptide of SEQ ID NO: 4. 
     
     
         40 . The recombinant host cell of  claim 33 , wherein the GH61 polypeptide is a fragment of the mature polypeptide of SEQ ID NO: 4, and wherein the fragment has cellulolytic enhancing activity. 
     
     
         41 . A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising: cultivating the recombinant host cell of  claim 33  under conditions conducive for production of the GH61 polypeptide, and recovering the GH61 polypeptide.

Join the waitlist — get patent alerts

Track US2019249159A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.